coralyne has been researched along with paclitaxel in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Badana, AK; Kumari, S; Malla, R; Mohan, GM; Shailender Naik, G | 1 |
| Badana, AK; Kumari, S; Malla, RR; Mohan, MG; Shailender, G | 1 |
2 other study(ies) available for coralyne and paclitaxel
| Article | Year |
|---|---|
Synergistic effects of coralyne and paclitaxel on cell migration and proliferation of breast cancer cells lines.
Topics: Berberine Alkaloids; Breast Neoplasms; Cell Adhesion; Cell Death; Cell Movement; Cell Proliferation; Drug Interactions; Drug Synergism; Female; Gene Expression Regulation, Neoplastic; Humans; Inhibitory Concentration 50; MCF-7 Cells; Neoplasm Proteins; Paclitaxel; RNA, Messenger | 2017 |
Synergistic enhancement of apoptosis by coralyne and paclitaxel in combination on MDA-MB-231 a triple-negative breast cancer cell line.
Topics: Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Ataxia Telangiectasia Mutated Proteins; Berberine Alkaloids; Caspase 3; Cell Line, Tumor; DNA Damage; DNA Fragmentation; Drug Synergism; Female; G1 Phase Cell Cycle Checkpoints; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Humans; Matrix Metalloproteinase 9; Paclitaxel; Triple Negative Breast Neoplasms | 2019 |